ERIC PAUL BENNETT

Scientist

[Nature Chemical Biology @nchembio]

A new paper from @WilsonLab2 @TimmKoller @MartinoMorici reports structures of the O-glycosylated antimicrobial peptide Drosocin in complex with the bacterial ribosome, revealing how Drosocin inhibits the termination phase of protein synthesis. Open access: https://t.co/O6mKxVyB4b

[ERIC PAUL BENNETT @ERICPBENNETT]

@pdhsu We are digging into this, chemestries are quite different, so assays not directly transferable, but so far they generate comparable data.

[ERIC PAUL BENNETT @ERICPBENNETT]

@pdhsu Precise Integration of Inducible Transcriptional Elements (PRIITE) enables absolute control of gene expression. For more information check out R.Pinto et al., NAR, 2017!

[ERIC PAUL BENNETT @ERICPBENNETT]

@BagdonaiteIeva @cphglyco @WandallLab @jcpJim Very interesting study!

[ERIC PAUL BENNETT @ERICPBENNETT]

Congrats with the move Patrick! Exiting times, I'm sure you'll do great!

[Patrick Hsu @pdhsu]

Excited to announce that my lab is moving this fall to @BerkeleyBioE. We develop new biotechnologies (and not just CRISPR-Cas!) to control brain and immune cell function for improving human health. Hiring at all levels (postdocs, grad students, RAs) - https://t.co/MFhG34kwWm

[ERIC PAUL BENNETT @ERICPBENNETT]

After overwhelming interest and thanks to great talks by: Samantha Maragh, Roberto Nitsch, Marcello Maresca, Jason Potter, Casey Jowdy, Kevin Holden, and others, this years 6th annual Precision CRISPR mini-symposium, became a great success. Heads up for our next event, next year!

[ERIC PAUL BENNETT @ERICPBENNETT]

Thanks to all students for a successful end of the 4th bi-annual 2 week Ph.D Course “Gene Targeting and Editing”. Students gained hands-on experience with anti-sense, CRISPR/Cas9 in bacteria, CRISPR/Cas9, ZFN and TALEN in mammalian cells and learn how to perform T7EI and IDAA.

[ERIC PAUL BENNETT @ERICPBENNETT]

The full program for the forthcoming “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing��, mini-symposium is now available. Interest has been overwhelming and we look forward to an exciting event with presentations from…https://t.co/Nc4IVTMwbH

[ERIC PAUL BENNETT @ERICPBENNETT]

Pleased to welcome You All to our yearly CRISPR mini-symposium entitled: “Precision CRISPR: Applications, Standardization and Reproducibility of Genome Editing”, Mini-symposium, August 30th, 2019!
https://t.co/B8qARv5BKA

[ERIC PAUL BENNETT @ERICPBENNETT]

Great opportunity for pre- and post –graduate students to catch up on the basics and translational aspects of CRISPR/Cas9 gene editing!
https://t.co/pk5b1qLigc

[ERIC PAUL BENNETT @ERICPBENNETT]

@jcornlab @BeekeWienert @staciakwyman @richardson_lab Congrats to a great scientific contribution!

[ERIC PAUL BENNETT @ERICPBENNETT]

@jcornlab @BeekeWienert @staciakwyman @richardson_lab Congrats to a great scientific contribution

[ERIC PAUL BENNETT @ERICPBENNETT]

Cobo Technologies has been enrolled in the US NIST Genome Editing Consortium. A great opportunity for Cobo Technologies to contribute and interact on establishing guidelines and “best practice” procedures for measuring genome editing outcomes.
https://t.co/Hix7W3ilnK

[ERIC PAUL BENNETT @ERICPBENNETT]

Instant identification and quantification of ex vivo CRISPR/Cas9 editing outcomes in primary cells! Our detailed protocol can be found in the "CRISPR Gene Editing methods and Protocols" collection that is finally out.
https://t.co/WXy5UXVCuq

[ERIC PAUL BENNETT @ERICPBENNETT]

Looking forward to present and network at the Therapeutic Genome Editing Congress, March 20th-21st  in Boston, with presence of leading institutions in the genome editing field.

https://t.co/8Me86yliff

[ERIC PAUL BENNETT @ERICPBENNETT]

Hello Twitter! #myfirstTweet